ESTIV 2024 | Prague | 3 - 6 June 2024
During ESTIV 2024 in Prague, the board of ecopa was proud to assign the ecopa award to Vito Vito D’Alessandro presenting the poster: “Development of a novel riboswitch-based cellular model of TDP-43 proteinopathy with a poster presentation titled “In vitro study of the effect of PFAS on the antibody production”.
The poster contained data about the possibility to generate a model for Amyotrophic Lateral Sclerosis (ALS), to improve the understanding of ALS related proteinopathies and facilitating the development of therapeutic strategies.
This study addresses the pressing need for improved ALS models and lays the groundwork for more advanced in vitro systems with enhanced translational relevance.